Szigetszentmiklos, Hungary

Monika Mezovari


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Monika Mezovari

Introduction

Monika Mezovari, an innovative inventor based in Szigetszentmiklos, Hungary, has made significant contributions to the field of pharmaceuticals. With a dedicated focus on crystalline forms of active pharmaceutical ingredients, Mezovari has successfully patented a breakthrough that addresses critical health issues.

Latest Patents

Monika Mezovari holds a notable patent for her invention related to "Crystalline pharmaceutically active ingredients." This invention specifically involves crystalline forms of rosuvastatin zinc (2:1) salt, presenting polymorphs that exhibit efficacy in treating various diseases related to lipid metabolism, including hypercholesterolemia, hyperlipidemia, dyslipidemia, and atherosclerosis. This patent highlights her commitment to advancing medical solutions for serious health conditions.

Career Highlights

Currently, Mezovari is associated with Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, a prominent pharmaceutical company. Her work primarily focuses on the development of synthetic compounds with therapeutic benefits, showcasing her expertise and dedication to pharmaceutical innovation.

Collaborations

Throughout her career, Monika has collaborated with talented professionals in the industry, including Imre Markovits and Ferenc Jurak. These partnerships not only enhance her research but also foster an environment of creativity and innovation within their collective work.

Conclusion

Monika Mezovari exemplifies the spirit of innovation in the pharmaceutical field with her groundbreaking patent and collaboration efforts. Her contributions are vital in the ongoing quest to improve health outcomes through advanced therapeutic solutions. As she continues her work, the impact of her innovations will undoubtedly resonate throughout the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…